Clinical Trial Update: A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates bevacizumab (Avastin) in combination with transarterial chemoembolization (TACE) for hepatocellular carcinoma, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29